Meditransfer Centrum Transferu Technologii Iitdsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
The Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences conducts research in clinical immunology, experimental cancer therapy, glycoimmunology, infection immunology and immunopharmacology. It also works on bacteriophages and phage therapy, molecular microbiology, virology, molecular biology, biochemistry and biotechnology. The institute can award doctoral and habilitation degrees in biological and medical sciences.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Dr Mateusz Noszka awarded the Prime Minister's Award
Professor Andrzej Górski awarded the Prime Minister's Award
Hirszfeld Institute awarded three more grants in the 10th edition of the NCN Miniatura competition
Dr Daria Artyszuk honored at the 30th Jubilee Congress of the Polish Microbiological Society
Public defense of the doctoral dissertation by Dr. Anna Tomasiewicz
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-04-01. Active
65 1140 1140 0000 2283 9100 1002
03 1020 5226 0000 6802 0770 1917- 75 1020 2241 0000 2502 0074 9374
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 23, 2023 | Aid for research and development projects: experimental development | –– | Prezes Agencji Badań Medycznych | |
| Oct 23, 2023 | Aid for research and development projects: industrial research | –– | Prezes Agencji Badań Medycznych |
Tenders
2 tenders recorded as contractor, with a total value of $381,710.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Feb 24, 2026 | Wykonanie systemu do laboratorium genetycznego wraz z narzędziami analitycznymi | $216.0K$215,964 | Instytut Immunologii I Terapii Doświadczalnej Im.Ludwika Hirszfelda Pan we Wrocławiu | |
| Jul 15, 2025 | Usługa zarządzania procesami rozwoju i komercjalizacji innowacji | $165.7K$165,746 | Instytut Immunologii I Terapii Doświadczalnej Im.Ludwika Hirszfelda Pan we Wrocławiu |
Authorized Representatives
Manner of representation
If the management board is multi-member, each member of the management board is authorised independently to make declarations of will on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Instytut Immunologii I Terapi Doświadczalnej Im. Ludwika Hirszfelda Polskiej Akademii Nauk We Wrocławiu | 10 | $135.06 | 0.1748% |
Others | 5,710 | $77,120.48 | 99.8252% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | ||
| Specjalistyczne Gabinetysp. z o.o. | $239,872.14 | specjalistycznegabinety.pl | ||
| Oncotarget Wojciech JurczakS.K.A. | $192,291.27 | oncotarget.pl | ||
| Cezamat Pwsp. z o.o. | $119,656.05 | cezamat.eu | ||
| CBK Med Clinicsp. z o.o. | $91,889.00 | cbkmedclinic.pl | ||
| Biostat Research and Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-23 | Name change (Centrum Transferu Technologii Meditransfer Iitd → Meditransfer Centrum Transferu Technologii Iitd) | |
| 2026-09-23 | Share capital change (276,000.00 PLN → 286,000.00 PLN) | |
| 2022-09-23 | Name change (Centrum Transferu Technologii Iitd → Centrum Transferu Technologii Meditransfer Iitd) | |
| 2022-09-23 | PKD change (Added: 72.11.Z, 72.19.Z, 82.30, 85.60.Z) | |
| 2018-09-05 | Share capital change (274,000.00 PLN → 276,000.00 PLN) |
FAQ
Last updated: 2026-10-02